SCHEMBL6766096

SCHEMBL6766096

[O]Cc1ccccc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5350956 0.78 HSPA5 (0.38)
SCHEMBL31294224 0.78
SCHEMBL7908778 0.78
SCHEMBL427621 0.78
SCHEMBL21380597 0.77 HSPA5 (0.46)
SCHEMBL5174795 0.77 IDO1 (0.36)
SCHEMBL7740624 0.76 GABRA1 (0.44)
SCHEMBL28747958 0.76 GABRA1 (0.44)
SCHEMBL4005028 0.74
SCHEMBL5422512 0.74 ALDH1A1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730788-B1 COUPLING WITH KETONE IN PRESENCE OF LANTHANIDE II METAL COMPOUND UNIVERSITY OF NOTRE DAME 2004-05-04 US disclosed
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed